According to the 54-nation African Union statement late on Monday, Covishield’s exclusion could lead to discrimination against African travelers.
Covishield which is produced by the Serum Institute of India (SII) and is distributed to African nations as part of the COVAX initiative to give developing countries access to COVID-19 vaccines.
It is not one of four vaccines approved by the European Union for its planned digital vaccination certificate, which is intended to allow people to travel freely within the EU.
The statement adds that the non-recognition of Covishield endangers the “equitable treatment of persons having received their vaccines in countries profiting from the EU-supported COVAX Facility, including the majority of the African Union (AU) Member States.”
The travel certificate will show if a person has received a vaccine, had a recent negative test, or had immunity based on recovery.
It will take the form of a QR (Quick Response) code on a smartphone or paper, letting authorities determine the status of a visitor based on records in their home country.